practice, gene analysis is performed to confirm it and to determine the causative mutation. Most children with RTT are the born from a normal pregnancy and delivery (Dolce, Ben-Zeev, Naidu, & Kossoff, 2013 ). An initial period of apparently normal development (ages 6-12 months) is followed by a period of rapid decline with regression of acquired motor skills, loss of spoken language and purposeful hand use, onset of hand stereotypes, abnormal gait, and growth failure. This regression is sometimes sudden and often rapid, occurring in the time span of weeks to months and usually this period is associated with severe sleep disturbances, irritability, and poor eye contact (Dolce et al., 2013) . According to revised diagnostic criteria for RTT by Neul et al., in classic RTT, a period of regression followed by recovery or stabilization and the presence of four main criteria and two exclusion criteria are required for diagnosis ; Table 1 ). With regard to postnatal deceleration in head growth, it is an early sign, which begins between 2 and 4 months of age (Dolce et al., 2013) . Nevertheless, it is not found in all patients with typical RTT (Hagberg, Stenbom, & Witt Engerstrom, 2000) ; for this reason, it has been eliminated from the necessary criteria, but it is considered nowadays a preamble to them, as a feature that should raise suspicion for the diagnosis .
The course of the disease, in its classical form, is characterized by four stages with an apparently normal early psychomotor development in the first 6 months of life (Hagberg et al., 2002;  Table 2 ).
In some cases, vague symptoms may be present, such as hypotonia, jerkiness, and reduced social interaction. Einspieler et al. carefully assessed videos of 22 Rett cases, examining movements, posture, and behavior during the first 6 months of life. Authors demonstrated an abnormal quality of general movements (100%), tongue protrusion (62%), postural stiffness (58%), asymmetric eye opening and closing (56%), abnormal finger movements (52%), hand stereotypies (42%), bursts of abnormal facial expressions (42%), bizarre smile (32%), tremor (28%), and stereotyped body movements (15%) (Einspieler, Kerr, & Prechtl, 2005) .
In addition to the classical form, it has been recognized that some individuals present with many of the clinical features of RTT but do not have all the features of this condition. These have been termed "variant" or "atypical" RTT: the preserved speech variant (Zappella variant), the congenital variant (Rolando variant), and the early seizure variant (Hanefeld variant). For the diagnosis of atypical or variant RTT, a period of regression followed by recovery or stabilization and at least two of the four main criteria and five of the 11 supportive criteria are needed  Table 3 ).
According to the data of the United States RTT National History Study, on a sample of 819 patients enrolled, 85.4% met diagnostic criteria for classic RTT and 14.6% for RTT variants .
Zappella variant is a clinical variant characterized by regression at 1-3 years, prolonged plateau phase, milder compromission of purposeful hand use, and milder intellectual disability. The distinctive feature of this variant is the recovery of language after regression, at a mean age of 5 years, along with the rarity of epilepsy. MeCP2 gene mutations are found in majority.
Rolando variant (or congenital variant) is characterized by severe psychomotor delay with inability to walk, severe postnatal microcephaly, regression in first 5 months, lack of typical RTT eye gaze, autonomic abnormalities (small cold hands and feet, peripheral vasomotor disturbances, breathing abnormalities while awake), and movement abnormalities (tongue stereotypes, jerky movements of the limbs).
Mutations in MECP2 gene are rarely found in this variant, which is closely linked to mutations in FOXG1 (Forkhead box protein G1) gene.
Hanefeld variant is characterized by early onset of seizures (infantile spasms and refractory myoclonic epilepsy) before regression, usually before 5 months of life. Other typical RTT features are less frequent. Also, in this variant, mutations in the MECP2 gene are rarely found, as it is characterized by mutations in the CDKL5 (cyclin-dependent kinase-like 5) gene, a regulator of MECP2 which also has important roles in neuronal maturation and brain development.
RTT is the major cause of mental retardation in females after Down syndrome (Krajnc, 2015) , but it has also been documented in normal female carriers, in females with variant forms, and in some males with Klinefelter syndrome, fatal encephalopathy, familial X-linked mental retardation, and males with features of RTT . As an X-linked disorder, RTT was considered lethal in males; however, males with clinical features of RTT were reported even before the discovery of the causal gene. Wan et al. first described a male patient with a congenital neonatal encephalopathy and mutation in MECP2, who died at 1 year of age . Males with MECP2 mutations fall into four categories: severe neonatal encephalopathy and infantile death; classical RTT; less severe neuropsychiatric symptoms; MECP2 duplication syndrome (Imessaoudene et al., 2001; Jülich, Horn, Burfeind, Erler, & Auber, 2009; Kyle, Vashi, & Justice, 2018; Meloni et al., 2000; Ramocki et al., 2009; Schwartzman, Bernardino, Nishimura, Gomes, & Zatz, 2001; Topҫu et al., 2002; Van Esch et al., 2005; Zeev et al., 2002;  (Ehrhart, Sangani, & Curfs, 2018) . MECP2 is a protein ubiquitously present throughout all human tissues and particularly abundant in neurons and astrocytes in the brain. It is expressed at low levels prenatally and increases during neuronal maturation and synaptogenesis suggesting an important role in neuronal activity and plasticity (Cohen et al., 2003; Jung et al., 2003; Samaco, Nagarajan, Braunschweig, & LaSalle, 2004 ). The exact mechanism by which loss of MECP2 results in the distinctive clinical features of RTT remains uncertain; it is supposed that abnormal cortical glutamatergic synaptic responses and excitatory connectivity result in excess of inhibition and deficits in neuronal plasticity (2012). MECP2 mutations usually occur de novo: in >99% of cases these mutations occur sporadically, in less than 1% are inherited from one parent (Dolce et al., 2013) ; familial cases originate from mutations inherited from healthy or mildly affected mothers or from gonadal mosaicism (Matijevic, Knezevic, Slavica, & Pavelic, 2009) . Majority of patients is therefore heterozygous for MECP2 mutation, carrying one normal and one mutated copy of the gene (Kyle et al., 2018; Neul et al., 2008) . Most of the de novo mutations occur almost exclusively in the paternal gamete (Trappe et al., 2001) . Currently, about 800 different mutations of MECP2 gene causing RTT have been identified: point mutations, insertions, duplications, small or large deletions in almost all parts of the gene (Ehrhart et al., 2018) . Majority of causative mutations has been found in eight single-nucleotide polymorphism hotspots as missense and nonsense mutations: T158M; R255X; R168X; R306C; R294X; R270X; R133C (Kyle et al., 2018; Percy et al., 2010) . These mutations account for approximately 70% of all mutations (Kyle et al., 2018) and R168X is the most common one; C-terminal deletions account for 8% and large deletions for another 5% (Neul et al., 2008) .
Despite the wide spectrum of MECP2 mutations and the variety of phenotype severity, there are no clear genotype-phenotype correlations (Guerrini et al., 2012) . Some studies in literature have proposed a correlation between genotype and clinical features in RTT patients (Cuddapah et al., 2014; Neul et al., 2008 commonly occur between patients with the same mutation.
Some possible explanation has been proposed, as differences in X chromosome inactivation (Ehrhart et al., 2018; Knudsen et al., 2006) and the presence of a second gene mutation, acting as modifier, alleviating or enhancing the phenotype outcome (Zeev et al., 2002) .
RTT was diagnosed also in 3%-5% patients who were negative for MECP2 mutations (Neul et al., 2008) . CDKL5 and FOXG1 are other genes identified as causative genes in atypical forms of RTT, respectively the Hanefeld Variant and Rolando variant (Ariani et al., 2008; Weaving et al., 2004) .
CDKL5 is a gene located on Xp22 and code for a ubiquitous protein, mainly expressed in the brain, thymus, and testes, with a role in neuronal maturation (Guerrini et al., 2012; Rusconi et al., 2008) .
Several mutations in the CDKL5 gene have been identified: point mutations, sequence variations resulting in missense, nonsense, splice and frameshift mutations, microdeletions, and larger rearrangements (Guerrini et al., 2012) . CDKL5 is involved in the early seizure variant of RTT Scala et al., 2005) . Table 5 ).
In classical or atypical clinical variants of RTT, a PCR-mutation screening of exons 3 and 4 of MECP2 gene should be first performed and, in the case of negativity, further screening for large deletions or small MECP2 mutations in exons 1 and 2 should be carried on.
In case of suspected early onset Rett syndrome, with epileptic seizures or spasms or microcephaly even in males, CDKL5 mutation screening and FOXG1 should follow.
In case of negativity, targeted resequencing consisting of ad hoc gene panels or whole exome sequency should then be recommended, together with an array CGH analysis to exclude microdeletions/ microduplications on the whole chromosomal set. The high banding karyotype may have priority in males with Rett-like phenotype and possible XXY aneuploidy.
| EPILEPSY IN RE T T SYNDROME
Epilepsy has been reported in 60%-80% of patients with RTT, differing among the various phenotypes and genotypes. Incidence is higher in patients with early onset RTT and more severe developmental disabilities (greater impairment of ambulation, hand use, and communication) . On the other hand, the severity of epilepsy is an important contributor to the clinical severity of RTT phenotype (Krajnc, 2015) . Seizures seem to occur earlier in those patients who do not have MECP2 mutations (Jian et al., 2006) .
There is not a characteristic "first seizure" semiology in Rett syndrome (Dolce et al., 2013) and all seizure types have been reported (Krajnc, 2015) . Complex partial and generalized tonic-clonic are the commonest seizure types in RTT (Pintaudi et al., 2010) , whereas absence and clonic seizures are less frequent (Buoni et al., 2008; Steffenburg, Hagberg, & Hagberg, 2001 ). Moreover, also early febrile seizures seem to be more frequent in RTT compared with general population (12% vs. 2%-5%) (Nissenkorn et al., 2010) . EEG is an important diagnostic tool because it allows to distinguish true seizures from nonepileptic events. However, it is important to consider that EEG can be abnormal in Rett syndrome, even without the presence of epilepsy in comorbidity; in such cases a prolonged video EEG could help clinicians (Dolce et al., 2013 (Tarquinio et al., 2017) .
| Epilepsy on MECP2-positive patients
With regard to classical form, seizures usually appear in the II or III stage of the disease, with the highest frequency occurring between 7 and 12 years (Krajnc, 2015) .
Reviewing literature, severe mutations in MECP2 gene, such as large deletions, early truncating, and missense mutations in the methyl-binding domain or the nuclear localizing segment seem to be associated with earlier or more sever epilepsy, whereas milder mutations such as late truncating or C-terminal deletions seem to have a protective effect on epilepsy onset (Jian et al., 2006 (Jian et al., , 2007 Nectoux et al., 2008; Pintaudi et al., 2010) . Rett subgroup) and seizures reported in 59% of those patients with MECP2 mutations and in 73% of those without MECP2 mutations. In the first subgroup, 60% of patients had a mutation in one of the eight most common mutations (R106W, R133C, T158M, R168X, R255X, R270X, R294X, R160C), 9% had C-terminal deletions and 8,5% had large deletions. Among all, seizures were more frequent in patients with T158M mutation (Guerrini et al., 2012) . This finding is consistent with a previous one by Glaze et al., who found significantly more epilepsy in patients with T158 mutation and R106W, than subjects with R255X or R306C mutations . Furthermore, Buoni et al. had formerly reported a higher prevalence of the T158 mutation in drug-resistant epilepsy (Buoni et al., 2008) . SCG2, IZUMO4, XAB2,  ZSCAN12, IQSEC2, FAM151A,  SYNE2, SMC1A, ARHGEF10L,  HDAC1, TAF1B, KCNJ10, CHD4,  LRRC40, LAMB2, GRIN2B,  IMPDH2, SAFB2, ACTL6B,  STXBP1, TRRAP, WDR45,  SLC39A13, FAT13, IQGAP3,  NCOR2, GABRB2, TCF4, 
| Epilepsy on CDKL5-positive patients
The early seizure variant (Hanefeld variant), associated with CDKL5 mutations, is characterized by seizure onset before 5 months of age, usually with infantile spasms (50%) and refractory myoclonic epilepsy (25%) (Dolce et al., 2013; Pintaudi et al., 2010 
| Epilepsy on FOXG1-positive patients
Severe early onset epilepsy has been reported as main features of the FOXG1-related phenotype (Guerrini et al., 2012 with onset between 3 months and 6 years (Kortüm et al., 2011) .
Moreover, the association between 14q12 duplication including FOXG1 and infantile spasms has been documented (Striano et al., 2011) , suggesting that overexpression of FOXG1 could have a specific role in the pathogenesis of infantile spasms.
| EEG FIND ING S
In literature, there are few reports of the characteristics EEG findings in patients with Rett syndrome, especially with regard to atypical variants (Figure 1 ).
| EEG on MECP2-positive patients
In classical form, EEG pattern progress through the four clinical stages of the disease, however with abnormalities that are not di- of background activity, theta activity in central and frontal regions, multifocal epileptiform activity in awake state, and generalized slow spike-wave activity in sleep (Dolce et al., 2013; Moser, Weber, & Lutschg, 2007) .
EEG findings that have been described as correlate of these ictal events are bilateral and synchronous initial flattening, followed by repetitive sharp waves and spikes; generalized ictal patterns in neonates or very young infants, atypical hypsarrhythmia, slowing background with multifocal interictal discharges, and suppression burst pattern (Grosso et al., 2007; Guerrini et al., 2012; Melani et al., 2011) .
| EEG on CDKL5-positive patients
Limited information is available regarding the precise electroclinical phenotype in epileptic patients with mutations in CDKL5 gene. 
| EEG on FOXG1-positive patients
To our knowledge, there are few reports concerning EEG findings in patients with RTT phenotype associated with FOXG1 mutations. Available EEG data only report focal and multifocal abnormalities in patients with tonic, generalized tonic-clonic and complex partial seizures (Guerrini et al., 2012; Kortüm et al., 2011) .
| CON CLUS IONS
Rett syndrome is a truly complex neurological disorder, whose diagnostic criteria are based on phenotypic description. In addition to the classical form, a heterogeneous spectrum of phenotypes identifies those forms called "atypical Rett". Nowadays, it seems more correct to consider this broad spectrum of neurological disorders as the expression of a complex encephalopathy. Epilepsy is a prominent symptom in RTT and it substantially contributes to the severity of the disease. Some genotypes are reported to be more frequently associated with epilepsy and even with a drug-resistant course. Recognizing clinical and EEG patterns in different RTT variants may be useful in diagnosis and management of these patients.
Long-term video EEG is surely a useful diagnostic tool which allows to differentiate between nonepileptic paroxysmal events and real epileptic seizures, to further classify seizure semiology and finally choice the most appropriate drug treatment. On the other hand, the identification of individual genetic background allows to diagnose the disorder properly and is helpful for treatment, not only for the genetic counseling.
In this manuscript, we aimed to clear-up the long-standing misunderstanding of differential diagnosis between Rett syndrome associated with MECP2 mutations and Rett-like phenotype of other neurodevelopmental diseases associated with different emerging genes.
Comparative studies with large cohorts of patients are needed to better understand the relationship between genotype and phenotype and correctly diagnose and treat these patients.
F I G U R E 1 EEG pattern of (a) a classical Rett syndrome, (b) a child with FOXG1 microduplication and epileptic spasms and microcephaly, (c) a 4-month CDKL5 girl with tonic/vibratory seizure followed by a cluster of spasms and clonic jerks
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